TITLE

Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy

AUTHOR(S)

Guojun Chen; Yali Wang; Zhenyu Xu; Feng Fang; Renmei Xu; Yue Wang; Xiaoli Hu; Lixing Fan; Houqi Liu

PUB. DATE

March 2013

SOURCE

Journal of Translational Medicine;2013, Vol. 11 Issue 1, p1

SOURCE TYPE

Academic Journal

DOC. TYPE

Article

ABSTRACT

Background: Stem cell therapy is a promising treatment for cerebral palsy, which refers to a category of brain diseases that are associated with chronic motor disability in children. Autologous MSCs may be a better cell source and have been studied for the treatment of cerebral palsy because of their functions in tissue repair and the regulation of immunological processes. Methods: To assess neural stem cell-like (NSC-like) cells derived from autologous marrow mesenchymal stem cells as a novel treatment for patients with moderate-to-severe cerebral palsy, a total of 60 cerebral palsy patients were enrolled in this open-label, non-randomised, observer-blinded controlled clinical study with a 6-months follow-up. For the transplantation group, a total of 30 cerebral palsy patients received an autologous NSC-like cells transplantation (1-2 × 107 cells into the subarachnoid cavity) and rehabilitation treatments whereas 30 patients in the control group only received rehabilitation treatment. Results: We recorded the gross motor function measurement scores, language quotients, and adverse events up to 6 months post-treatment. The gross motor function measurement scores in the transplantation group were significantly higher at month 3 (the score increase was 42.6, 95% CI: 9.8-75.3, P=.011) and month 6 (the score increase was 58.6, 95% CI: 25.8-91.4, P=.001) post-treatment compared with the baseline scores. The increase in the Gross Motor Function Measurement scores in the control group was not significant. The increases in the language quotients at months 1, 3, and 6 post-treatment were not statistically significant when compared with the baseline quotients in both groups. All the 60 patients survived, and none of the patients experienced serious adverse events or complications. Conclusion: Our results indicated that NSC-like cells are safe and effective for the treatment of motor deficits related to cerebral palsy. Further randomised clinical trials are necessary to establish the efficacy of this procedure.

ACCESSION #

85955444

 

Related Articles

• Histological and Immunohistochemical Evaluation of Autologous Cultured Bone Marrow Mesenchymal Stem Cells and Bone Marrow Mononucleated Cells in Collagenase-Induced Tendinitis of Equine Superficial Digital Flexor Tendon. Crovace, Antonio; Lacitignola, Luca; Rossi, Giacomo; Francioso, Edda // Veterinary Medicine International;2010, p1 

  The aim of this study was to compare treatment with cultured bone marrow stromal cells (cBMSCs), bone marrow Mononucleated Cells (BMMNCs), and placebo to repair collagenase-induced tendinitis in horses. In six adult Standardbred horses, 4000 IU of collagenase were injected in the superficial...

• Comprehensive Effects of Suppression of MicroRNA-383 in Human Bone-Marrow-Derived Mesenchymal Stem Cells on Treating Spinal Cord Injury. Guo-Jun Wei; Ke-wen Zheng; Gang An; Zuo-Wei Shi; Kai-Fu Wang; Ying Guan; Yan-Song Wang; Peng-Fei Li; Da-Ming Dong // Cellular Physiology & Biochemistry (Karger AG);2018, Vol. 47 Issue 1, p129 

  Background/Aims: Transplantation of bone-marrow-derived mesenchymal stem cells (MSCs) promotes neural cell regeneration after spinal cord injury (SCI). Recently, we showed that suppression of microRNA-383 (miR-383) in MSCs increased the protein levels of glial cell line derived neurotrophic...

• Immunological effect induced by mesenchymal stem cells in a rat liver transplantation model. HAIJIANG WANG; ZHENQIANG SUN; TAO LI; HAO WEN; WEIZHENG JI; YAN MA // Experimental & Therapeutic Medicine;Aug2015, Vol. 10 Issue 2, p401 

  The aim of the present study was to investigate the immunological effect induced by bone marrow mesenchymal stem cells (MSCs) in rats that had undergone an orthotopic liver transplantation (OLT). MSCs were isolated and cultured from the bone marrow tissue of Lewis rats. In total, 42 rat OLT...

• Mesenchymal Stem Cells Promote Cardiac Muscle Repair via Enhanced Neovascularization. Zhang, Jianfeng; Wu, Yicheng; Chen, anqing; Zhao, Qiang // Cellular Physiology & Biochemistry (Karger AG);Feb2015, Vol. 35 Issue 3, p1219 

  Background/Aims: Transplantation of bone-marrow derived stem/progenitor cells has an established therapeutic effect on cardiac muscle repair after injury. However, the exact mechanism that underlies this phenomenon is not completely understood. Methods: Here we transplanted mesenchymal stem...

• Characteristics and response of mouse bone marrow derived novel low adherent mesenchymal stem cells acquired by quantification of extracellular matrix. Ri-Cheng Zheng; Seong-Kyun Kim; Seong-Joo Heo; Jai-Young Koak; Joo-Hee Lee; Ji-Man Park // Journal of Advanced Prosthodontics;Oct2014, Vol. 6 Issue 5, p351 

  PURPOSE. The aim of present study was to identify characteristic and response of mouse bone marrow (BM) derived low-adherent bone marrow mesenchymal stem cells (BMMSCs) obtained by quantification of extracellular matrix (ECM). MATERIALS AND METHODS. Non-adherent cells acquired by ECM coated...

• In vitro neural differentiation of bone marrow stromal cells induced by hepatocyte growth factor and glial cell derived neurotrophic factor. MA, Q.; CAI, M.; SHANG, J.-W.; YANG, J.; GU, X.-Y.; LIU, W.-B.; YANG, Q. // European Review for Medical & Pharmacological Sciences;Nov2016, Vol. 20 Issue 22, p4654 

  OBJECTIVE: Bone marrow stromal cells (BMSCs) have great potential for cell-based transplantation therapy in treating neurological disease. However, the best combination of various trophic factors to produce full neural differentiation of BMSCs was still unclear. In our study, we aimed to...

• Bone Marrow Mesenchymal Stem Cell Transplantation Increases GAP-43 Expression via ERK1/2 and PI3K/Akt Pathways in Intracerebral Hemorrhage. Jianzhong Cui; Changmeng Cui; Ying Cui; Ran Li; Huaxin Sheng; Xiaohua Jiang; Yanxia Tian; Kaijie Wang; Junling Gao // Cellular Physiology & Biochemistry (Karger AG);Jun2017, Vol. 41 Issue 5, p137 

  Background/Aims: Intracerebral hemorrhage (ICH) occurs in hypertensive patients and results in high rates of mortality and disability. This study determined whether bone marrow mesenchymal stem cell (BMSC) transplantation affects axonal regeneration and examined the underlying mechanisms after...

• Nanog Overexpression Allows Human Mesenchymal Stem Cells to Differentiate into Neural Cells. Alvarez, Angel; Hossain, Monowar; Dantuma, Elise; Merchant, Stephanie; Sugaya, Kiminobu // Neuroscience & Medicine;Sep2010, Vol. 1 Issue 1, p1 

  Although stem cell therapies have been proposed as a candidate for treating neurological diseases, the best stem cell source and their therapeutic efficacy remain uncertain. Embryonic stem cells (ESCs) can efficiently generate multiple cell types, but pose ethical and clinical challenges, while...

• Advanced Age Impairs Cardioprotective Function of Mesenchymal Stem Cell Transplantation from Patients to Myocardially Infarcted Rats. Liu, Yu; Liu, Tao; Han, Jinsong; Yang, Zhonglu; Xue, Xiaodong; Jiang, Hui; Wang, Huishan // Cardiology;May2014, Vol. 128 Issue 2, p209 

  Objectives: Mesenchymal stem cells (MSCs) have limited clinical therapeutic effects in older myocardial infarction (MI) patients. Thus, whether younger MSCs might confer greater protection is worth investigating. Methods: Human MSCs (hMSCs) were isolated before coronary artery bypass graft...

Read the Article